Diabetes
Research and Training Centers
Six Diabetes Research and Training Centers
are funded by the National
Institutes of Health.
The Diabetes Prevention Trial is a national
study to test if it's possible to prevent Type 1 diabetes.
If you are between 3 and 45 and have a close relative with
Type 1 diabetes, you are eligible to be screened. The DPT-l
is a multi-centered study sponsored by the National
Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
in cooperation with other organizations including the American
Diabetes Association. Also visit Stanford
University's School of Medicine
A study to prevent type 2 diabetes, called the Diabetes
Prevention Program, has reached its goal of recruiting
3,000 participants and is no longer recruiting new volunteers.
Amyloid diabetes is the term that M.R. (Pete) Hayden, M.D.,
of Camdenton, Missouri, uses for what we usually call type
2 diabetes. Islet amyloid (a scar tissue) forms in the islets
of people with type 2 diabetes. "This scar tissue creates
a diffusion barrier and causes an insulin secretory defect
as well as an insulin absorptive defect around the vessels
within the islets of the pancreas," Dr. Hayden tells me. He
is a family physician on sabbatical to pursue his interest
in islet amyloid. The URL is http://www.amyloiddiabetes.com/
The
Virtual Health Care Team has written up a case about a
person with diabetic retinopathy and resulting low vision.
It describes medical treatment, rehabilitation principles,
and resources. It is one of the interdisciplinary cases sponsored
by the School of Health Professions and the School of Medicine,
University of Missouri, Columbia.
The
Web site of the Diabetes Center at the University of California
San Francisco includes its "eUpdate," a newsletter published
approximately once per month by its scientists and staff.
The
Endocrine Metabolic Medical Center in Redwood City, California
is a clinic for people with diabetes, diabetes complications,
or weight control issues. J. Joseph
Prendergast, M.D, email jjp@endocrinemetabolic.com
founded Endocrine Metabolic Medical Center in 1986.
Diabetes
One on One is a program for people with diabetes, their
families, and friends. The Endocrine Metabolic Medical Center
in Atherton, California, which Dr. Joseph Prendergast heads,
sponsors this program. A Diabetes Nurse Education serves as
the coach and resource to each member of the program. Support
is via phone and email.
Diabetes
Health Care Providers and Researchers in India consists
of information from professional organizations and academic
institutions and is a companion to the lay site, Asian Indians
with Diabetes at http://www.diabetes-india.com/
. They have the same Webmasters, Professor
P.V. Rao <mailto:raopaturi@yahoo.com> ,
the head of the Department of Endocrinology and Metabolism
of the School of Diabetology, Nizam's Institute of Medical
Sciences, and Dr. Paturi Ushabala <mailto:raopaturi@yahoo.com>
of the Diabetes Education and Treatment Center, both in Hyderabad,
India.
"Clinica
Diabetológica" is the Web site of Dr. Antuña de Alaiz <mailto:rantuna@arrakis.es>
in both Spanish and English. His clinic is in Gijón, Asturias,
Spain.
Transplantation
at the University of Minnesota was founded in 1994 to
develop and implement cures for diabetes through the disciplines
of transplantation and immunology.
The
Tallahassee Memorial Diabetes Center is one of the largest
diabetes treatment centers in the southeast.
SmithKline Beecham Pharmaceuticals, headquartered in London,
England, is conducting a
long-term research study to compare the effects of three FDA-approved
medications on Type 2 Diabetes. Qualified participants
will receive at no cost a physician's assessment, laboratory
tests, and study medication. They don't name the medications
(probably for regulatory reasons), but Avandia is probably
one of them, because it is their only FDA-approved medication.
The Naomi
Berrie Diabetes Center at Columbia-Presbyterian Medical Center
in Dallas emphasizes its family approach to care of patients
with diabetes.
The DiabCare
Quality Network in Europe is a European consortium of
partners in health care, industry, and research to improve
diabetes care through telemedicine.
The
International Diabetes Center in Minneapolis is part of
the Institute for Research and Education HealthSystem Minnesota.
HealthSystem Minnesota, an integrated care system, also includes
Methodist Hospital, Park Nicollet Clinic, and The Foundation.
The Center is a leader in the development, evaluation, and
implementation of education and treatment models designed
to improve the health and lives of people with diabetes.
The eMedicine.com
Web site has two detailed and technical articles about diabetes:
Diabetes
Mellitus, Type 1 - A Review, by Scott R. Votey, M.D.,
Associate Professor, Division of Emergency Medicine, University
of California at Los Angeles Medical Center and Anne L.
Peters, M.D., Director of Clinical Diabetes Program, Associate
Professor of Medicine, UCLA Department of Medicine, UCLA
Medical Center.
Diabetes
Mellitus, Type 2 - A Review, also by Scott R. Votey,
M.D., Associate Professor, Division of Emergency Medicine,
University of California at Los Angeles Medical Center
and Anne L. Peters, M.D., Director of Clinical Diabetes
Program, Associate Professor of Medicine, UCLA Department
of Medicine, UCLA Medical Center.
Recombinant
Capital's search engine for biotech clinical trials is
an excellent resource to find out what upcoming diabetes drugs
are being studied. Hint: enter the word diabetes in the text
string field at the bottom of the form without entering any
other values and click on the search button.
The
CenterWatch Clinical Trials Listing Service is a listing
of ongoing clinical research trials run by a publishing company
that focuses on the clinical trials industry. You can use
this listing to search for clinical trials, find out information
about physicians and medical centers performing clinical research,
and to learn about drug therapies recently approved by the
Food and Drug Administration.
Diagnosis
and Management of Type 2 Diabetes, Monograph No. 1, 1999,
is an American Family Physician monograph designed to
provide family physicians with high-quality continuing medical
education that reflects the spectrum of family practice. The
on-line and print versions of these monographs are identical.
The
American Academy of Family Physicians released "The Benefits
and Risks of Controlling Blood Glucose Levels in Patients
With Type 2 Diabetes Mellitus" in August 1999. This review
of the evidence and recommendations is available in a 39-page
PDF document.
Dr.
Stuart Brink, M.D., is the senior endocrinologist at NEDEC,
the New England Diabetes & Endocrinology Center in Waltham,
Massachusetts.
The Biochemistry of Type 1 and 2 Diabetes Mellitus is by
Michael W. King, Ph.D., Associate Professor of Biochemistry
and Molecular Biology, at the
Indiana University School of Medicine. This page is especially
valuable in describing the ICCA, ICSA, and AntiGAD antibodies
by which type 1 diabetes is most positively diagnosed.
The
Endocrine Pancreas: Introduction and Index is a first-rate
professional introduction. It is a part of the Biomedical
Hypertextbooks from Colorado State University in Fort Collins,
Colorado.
The
University of Texas Health Science Center at San Antonio Department
of Orthopaedics/Podiatric Service has an extensive information
about foot care.
The
Diabetes Control Center is a Web site is dedicated to
shining light on the bad news of diabetes, so that it can
be avoided, and broadcasting the good news for the sake of
good health. The site addresses the potential complications
of diabetes and how they can be prevented. It also includes
tips for handling for sick days and provides diet information.
The site was constructed by Charles
H. Raine, III, M. D. <mailto:doc@dr-diabetes.com>
a specialist in diabetes who also has the disease, takes insulin,
and regularly checks his blood sugar.
Nancy J. Bohannon, MD, a San Francisco specialist in endocrinology
and metabolism, writes me that she does respond to e-mail
requests by forwarding copies of her papers when they seem
appropriate, including vulvovaginal candidiasis in diabetic
women, coronary artery disease in people with diabetes specifically
and also in other special populations such as women and smokers,
and her research, including information on pimagedine, Humalog,
insulin pens, new monitors, and inhaled insulin. "I do have
concerns," she writes, "about advice given to people who are
not established patients and so do not advise them except
regarding general info such as enhanced glucose monitoring."
Her office phone is (415) 648-7622, her website is www.mydoctor.com/sugarnancy
and her e-mail address is SugarNancy@pol.net
<mailto:SugarNancy@pol.net
The
Beth Israel Deaconess Medical Center's Division of Vascular
Surgery in Boston is a leading center for the treatment
of the vascular complications of diabetes, especially for
problems of the diabetic foot. Their techniques have led to
a marked reduction in the need for amputation commonly associated
with diabetes. This care is multidisciplinary, and access
to care is by calling the Diabetic Foot Center (1-888-FEET)
or by selecting and calling directly any member of the Vascular
Surgery staff.
The
Texas Diabetes Institute in San Antonio focuses on type
2 diabetes.
The
University of Utah Medical School can show you microscopic
views of the pancreas, kidneys, eyes, and other tissues of
diabetic patients. These images of the "Pathology of Diabetes
Mellitus" illustrate why good control is important.
The
Web site of the "Joslin Diabetes Center DNA Core Facility"
offer information to researchers on DNA sequencing, DNA
synthesis and DNA Fragment Analysis and how the Core provides
these services.
The
Department of Anaesthesia in Basel, Switzerland, includes
the "Resident's Electronic Handbook for Diabetes mellitus."
|
